Growth Metrics

Exagen (XGN) Income from Continuing Operations (2018 - 2025)

Exagen (XGN) has disclosed Income from Continuing Operations for 8 consecutive years, with 6275000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income from Continuing Operations fell 67.38% year-over-year to 6275000.0, compared with a TTM value of 21516000.0 through Dec 2025, down 42.46%, and an annual FY2025 reading of 19951000.0, down 31.99% over the prior year.
  • Income from Continuing Operations was 6275000.0 for Q4 2025 at Exagen, up from 7087000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 2966000.0 in Q2 2024 and bottomed at 15117000.0 in Q4 2022.
  • Average Income from Continuing Operations over 5 years is 6781000.0, with a median of 6242000.0 recorded in 2021.
  • The sharpest move saw Income from Continuing Operations plummeted 128.86% in 2022, then soared 65.83% in 2023.
  • Year by year, Income from Continuing Operations stood at 7053000.0 in 2021, then crashed by 114.33% to 15117000.0 in 2022, then skyrocketed by 63.35% to 5540000.0 in 2023, then soared by 32.33% to 3749000.0 in 2024, then plummeted by 67.38% to 6275000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for XGN at 6275000.0 in Q4 2025, 7087000.0 in Q3 2025, and 4402000.0 in Q2 2025.